Secukinumab in plaque psoriasis – results of two phase 3 trials - Langley, R G; Elewski, B E; Lebwohl, M; Reich, K; Griffiths, C EM; Papp, K; Puig, L; Nakagawa, H; Spelman, L; Sigurgeirsson, B; Rivas, E; Tsai, T F; Wasel, N; Tyring, S; Salko, T; Hampele, I; Notter, M; Karpov, A; Helou, S; Papavassilis, C; ERASURE Study Group; FIXTURE Study Group (N Engl J Med, 2014)